BrainCool System

THE BRAINCOOL™ SYSTEM FOR STROKE

An estimated worldwide market potential of $3 billion annually.

THE BRAINCOOL™ SYSTEM FOR CARDIAC ARREST

Current annual sales by three major players (Bard / Medivance, Asah Kasei / Zoll and Philips Healthcare) $ 150 million* with an annual growth of 30–40% with a similar market potential as stroke.